Overcoming the Treatment-Risk Paradox for Intensive Blood Pressure Care

b'Patients most likely to benefit from intensive systolic blood pressure treatment (SBP) versus standard treatment to reduce cardiovascular disease (CVD) may also be at risk for adverse events (AE).